Chronic Antibiotic-Refractory Diversion Pouchitis Successfully Treated With Leukocyteapheresis

Therapeutic Apheresis and Dialysis

Volumn 18, Issue 6, 2014, Pages 644-645

  Watanabe, Chikako ^a   Hokari, Ryota ^a   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HEMOGLOBIN; METRONIDAZOLE; ANTIINFECTIVE AGENT;

AGED; APHERESIS; CASE REPORT; DIGESTIVE SYSTEM DISEASE ASSESSMENT; FEMALE; FLOW RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILEITIS; LETTER; LEUKOCYTEAPHERESIS; LOW DRUG DOSE; POUCHITIS DISEASE ACTIVITY INDEX; PRIORITY JOURNAL; CHRONIC DISEASE; LEUKAPHERESIS; POUCHITIS; PROCEDURES; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; FEMALE; HUMANS; LEUKAPHERESIS; POUCHITIS; TREATMENT OUTCOME;

EID: 84919630523     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12175     Document Type: Letter

References (4)

1. Shen B. Acute and chronic pouchitis-pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 2012;9:323-333.
2. Shibata H, Kuriyama T, Yamawaki N. Cellsorba. Ther Apher Dial 2003;7:44-47.
3. Matsumoto T, Andoh A, Okawa K etal. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study. Ther Apher Dial 2008;12:484-490.
4. Sandborn WJ, Tremaine WJ, Batts KP etal. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc 1994;69:409-415.